Rocbrutinib is an investigational new drug that is being evaluated by Newave Pharmaceuticals for the treatment of chronic lymphocytic leukaemia (CLL), diffuse large B cell lymphoma (DLBCL), and mantle cell lymphoma (MCL).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.